A two-stage phase I trial of evolence30 collagen for soft-tissue contour correction

Plastic and Reconstructive Surgery

Volumn 120, Issue 1, 2007, Pages 303-311

  Monstrey, Stan J ^a   Pitaru, Sandu ^b   Hamdi, Moustapha ^b   Van Landuyt, Koen ^b   Blondeel, Phillip ^b   Shiri, Joseph ^b   Goldlust, Arie ^b   Shoshani, David ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN IMPLANT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ADVERSE OUTCOME; ARTICLE; BIOCOMPATIBILITY; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; FACE; FACE SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION SITE; LABORATORY TEST; LIP; MALE; NASOLABIAL FOLD; NORMAL HUMAN; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; VALIDATION PROCESS; WRINKLE;

AGED; COLLAGEN; DOUBLE-BLIND METHOD; ESTHETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROBABILITY; REJUVENATION; RISK FACTORS; SKIN AGING; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34250721179     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000264402.97692.b6     Document Type: Article

References (14)

1. Rohrich, R. J., Rios, J. L., and Fagien, S.. Role of new fillers in facial rejuvenation: A cautious outlook. Plast. Reconstr. Surg. 112: 1899, 2003.
2. Cooperman, L., Mackinnon, V., Bechler, G., and Pharriss, B. B. Injectable collagen: A six-year clinical investigation. Aesthetic Plast. Surg. 9: 145, 1985.
3. Narins, R. S., Brandt, F., Leyden, J., Lorenc, Z. P., Rubin, M., and Smith, S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol. Surg. 29: 588, 2003.
4. Bailey, A. J., Paul, R. G., and Knott, L. Mechanism of maturation and ageing of collagen. Mech. Ageing Dev. 106: 1, 1998.
5. Zilla, P., Fullard, L., Trescony, P., et al. Glutaraldehyde detoxification of aortic wall tissue: a promising perspective for emerging bioprosthetic valve concepts. J. Heart Valve Dis. 6: 510, 1997.
6. Pitaru, S., Meidan, L., Noff, M., Pitaru, S., Goldlust, A., and Savion, N. A novel collagen-based biomatrix for long-term treatment of soft tissue defects. Presented at the 6th Annual Meeting of Tissue Engineering Society International, Canada, December 10-13, 2003.
7. Fitzpatrick, R. E., Goldman, M. P., Satur, N. M., and Tope, W. D. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch. Dermatol. 13: 395, 1996.
8. Watson, W., Kay, R. L., Klein, A. W., et al. Injectable collagen: A clinical overview. Cutis 3: 543, 1983.
9. Nicolle, F. V. Correction of age and disease related contour deficiencies of the face. Aesthetic Plast. Surg. 9: 159, 1985.
10. Matti, B. A., and Nicolle, F. V. Clinical use of Zyplast in correction of age and disease related contour deficiencies of the face. Aesthetic Plast. Surg. 14: 227, 1990.
11. Struck, H. Immunological investigations of antigenicity and specificity of soluble collagen fractions: IV. Anaphylaxis and allergy experiments. Eur. Surg. Res. 8: 243, 1976.
12. DeLustro, F., Smith, S. T., Sundsmo, J., Salem, G., Kincaid, S., and Ellingsworth, L. Reaction to injectable: Results in animal models and clinical use. Plast. Reconstr. Surg. 79: 581, 1978.
13. DeLustro, F., Mackinnon, V., and Swanson, N. A. Immunology of injectable collagen in human subjects. J. Dermatol. Surg. Oncol. 14 (Suppl. 1): 49, 1988.
14. DeLustro, F., Dasch, J., Keefe, J., and Ellingsworth, L. Immune response to allogenic and xenogenic implants of collagen and collagen derivates. Clin. Orthop. 260: 263, 1990.